Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Pleural Diseases 1Mesothelioma, Malignant 1Glioma 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 6Specimen Handling 5Magnetic Resonance Spectroscopy 4Ipilimumab 4HhAntag691 4CTLA-4 Antigen 3Biopsy 3prednylidene 2deltacortene 2daromun 2cemiplimab 2Standard of Care 2Prednisone 2talimogene laherparepvec 1sonidegib 1relatlimab 1X-Rays 1Watchful Waiting 1Vitamin D 1Therapeutics 1Tacrolimus 1Sunscreening Agents 1Sirolimus 1Radiotherapy 1Practice Guidelines as Topic 1Photochemotherapy 1Observation 1Niacinamide 1Mohs Surgery 1MAPRE1 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × 1-phenyl-3,3-dimethyltriazene × 90 days × Clear all
NCT05020912 2026-06-01

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Case Comprehensive Cancer Center

Phase 2 Active not recruiting
18 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡